title: Cryopreservation of oocytes and embryos: use of a mouse model to investigate effects upon zona hardness and formulate treatment strategies in an in-vitro fertilization programme.
abstract: Mouse oocytes and embryos were obtained following ovulation induction of (C57B16 x CBA) F1 animals. Zonae pellucidae were exposed to alpha-chymotrypsin in phosphate-buffered medium (PB1) supplemented with 3 mg/ml bovine serum albumin upon a heated stage (37 degrees C) and were observed constantly through an inverted microscope. The endpoint of the bioassay was the limits of the zona no longer being seen clearly at x 200 magnification, and the time taken for each zona to dissolve was recorded. A dose-dependent response in dissolution time was clearly seen, with 1% alpha-chymotrypsin being chosen as the routine working solution. Cryopreservation of 2-cell mouse embryos using propanediol did not cause zona hardening but induced a small and significant softening, as gauged by the time taken for zona dissolution (2181 +/- 167 versus 1864 +/- 82 s). Zona hardening was not suspected to occur after the freezing of human embryos as there was no difference in implantation rates per embryo for in-vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) treatment cycles between fresh [IVF: 63/644 (9.7%); ICSI: 51/330 (15.5%)] and frozen embryos [IVF: 36/458 (7.9%); ICSI: 18/112 (16.1%)]. Conversely, significant hardening of the zonae of mature oocytes was seen following cryopreservation (747 +/- 393 s) compared with freshly ovulated oocytes (151 +/- 68 s). It is concluded that (i) the freezing of murine oocytes with propanediol results in zona hardening, implying a possible benefit of ICSI after the cryopreservation of human oocytes, and (ii) the cryopreservation of embryos is not associated with zona hardening or reduced implantation, making microdissection of the zona in such cases generally unwarranted.
authors.affiliation: PIVET Laboratory, Leederville, Western Australia.
authors.forename: P L
authors.initials: PL
authors.lastname: Matson
authors.forename: J
authors.initials: J
authors.lastname: Graefling
authors.forename: S M
authors.initials: SM
authors.lastname: Junk
authors.forename: J L
authors.initials: JL
authors.lastname: Yovich
authors.forename: W R
authors.initials: WR
authors.lastname: Edirisinghe
mesh_terms: D000818:Animals; D002021:Buffers; D002918:Chymotrypsin / Q000494:pharmacology; D015925:Cryopreservation; D010064:Embryo Implantation; D004622:Embryo, Mammalian / Q000502:physiology*; D005260:Female; D005307:Fertilization in Vitro / Q000379:methods; D006358:Hot Temperature; D006801:Humans; D051379:Mice; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA; D008845:Microinjections; D009865:Oocytes / Q000502:physiology*; D010062:Ovulation Induction; D010710:Phosphates; D011247:Pregnancy; D011409:Propylene Glycols; D012710:Serum Albumin, Bovine; D015044:Zona Pellucida / Q000187:drug effects / Q000502:physiology*
chemical_list: D002021:Buffers; D010710:Phosphates; D011409:Propylene Glycols; D012710:Serum Albumin, Bovine; D002918:Chymotrypsin